Review
[Recent advance in the discovery of allosteric inhibitors binding to the AMP site of fructose-1,6-bisphosphatase]
[Article in
Chinese]
Affiliations
- PMID: 22260018
Item in Clipboard
Review
[Recent advance in the discovery of allosteric inhibitors binding to the AMP site of fructose-1,6-bisphosphatase]
[Article in
Chinese]
Yao Xue Xue Bao.
2011 Nov.
Abstract
Fructose-1, 6-bisphosphatase (FBPase), a rate-limiting enzyme involved in the pathway of gluconeogenesis, can catalyze the hydrolysis of fructose-1, 6-bisphosphate to fructose-6-phosphate. Upon inhibiting the activity of FBPase, the production of endogenous glucose can be decreased and the level of blood glucose lowered. Therefore, inhibitors of FBPase are expected to be novel potential therapeutics for the treatment of type II diabetes. Recent research efforts were reviewed in the field of developing allosteric inhibitors interacting with the AMP binding site of FBPase.
Similar articles
-
Allosteric FBPase inhibitors gain 10(5) times in potency when simultaneously binding two neighboring AMP sites.Bioorg Med Chem Lett. 2008 Aug 15;18(16):4708-12. doi: 10.1016/j.bmcl.2008.06.103. Epub 2008 Jul 5. Bioorg Med Chem Lett. 2008. PMID: 18650089
-
Structure-guided design of AMP mimics that inhibit fructose-1,6-bisphosphatase with high affinity and specificity.J Am Chem Soc. 2007 Dec 19;129(50):15480-90. doi: 10.1021/ja074869u. Epub 2007 Nov 28. J Am Chem Soc. 2007. PMID: 18041833
-
Discovery of potent and specific fructose-1,6-bisphosphatase inhibitors and a series of orally-bioavailable phosphoramidase-sensitive prodrugs for the treatment of type 2 diabetes.J Am Chem Soc. 2007 Dec 19;129(50):15491-502. doi: 10.1021/ja074871l. Epub 2007 Nov 28. J Am Chem Soc. 2007. PMID: 18041834
-
Fructose-1, 6-bisphosphatase inhibitors for reducing excessive endogenous glucose production in type 2 diabetes.Handb Exp Pharmacol. 2011;(203):279-301. doi: 10.1007/978-3-642-17214-4_12. Handb Exp Pharmacol. 2011. PMID: 21484576 Review.
-
Discovery of fructose-1,6-bisphosphatase inhibitors for the treatment of type 2 diabetes.Curr Opin Drug Discov Devel. 2007 Jul;10(4):430-7. Curr Opin Drug Discov Devel. 2007. PMID: 17659484 Review.
Cited by
-
Discovery of Novel Indole Derivatives as Fructose-1,6-bisphosphatase Inhibitors and X-ray Cocrystal Structures Analysis.ACS Med Chem Lett. 2021 Dec 20;13(1):118-127. doi: 10.1021/acsmedchemlett.1c00613. eCollection 2022 Jan 13. ACS Med Chem Lett. 2021. PMID: 35059131 Free PMC article.